The DEA move would reclassify marijuana from a Schedule I drug, alongside heroin, LSD and ecstasy, to a Schedule III drug.

Other Schedule III drugs, which have “a moderate to low potential for physical and psychological dependence,” include Tylenol with codeine, ketamine, anabolic steroids and testosterone, per the DEA.

Schedule I drugs are considered to have “no currently accepted medical use and a high potential for abuse.”